EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases


Gundogdu A. G. , Onder S. , Firat P., DOĞAN R.

JOURNAL OF THORACIC DISEASE, cilt.6, ss.778-784, 2014 (SCI İndekslerine Giren Dergi) identifier identifier

Özet

Background: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.